Emerald Mutual Fund Advisers Trust’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-49,916	Closed	-$2.55M	–	298
2016 Q2	$2.55M	Sell	49,916 -42,444	-46%	-$1.81M	0.14%	156
2016 Q1	$2.73M	Buy	92,360 +1,700	+2%	+$53.6K	0.15%	148
2015 Q4	$4.11M	Buy	+90,660	New	+$4.75M	0.22%	134

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's ONCE Position: Q3 2016 in Review

Emerald Mutual Fund Advisers Trust sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2016, closing a stake of 49,916 shares — an estimated $2.55M sold.

Emerald Mutual Fund Advisers Trust first reported a position in ONCE in Q4 2015 and held it in 3 quarters. The position peaked at $4.11M in Q4 2015. 121 funds tracked by Wall St. Rank hold ONCE as of Q3 2016.

Emerald Mutual Fund Advisers Trust reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 49,916 Spark Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $2.55M.
Emerald Mutual Fund Advisers Trust first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2015 and held it in 3 quarters.
Emerald Mutual Fund Advisers Trust's Spark Therapeutics, Inc. Common Stock position peaked at $4.11M in Q4 2015.
121 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2016, filed 27 Oct 2016.